FIELD: organic chemistry, medicine, oncology, pharmacy.
SUBSTANCE: invention relates to new stable crystalline forms of derivative of pyrimidine nucleoside of the formula (I) 
eliciting the excellent anti-tumor activity. Also, invention relates to pharmaceutical composition eliciting an anti-tumor effect, applying crystalline form for preparing medicinal agent and to a method for prophylaxis or treatment of tumor diseases.
EFFECT: improved method for prophylaxis and treatment, valuable medicinal properties of derivative.
10 cl, 2 tbl, 4 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUSPENSIONS OF CRYSTALLINE PYRIMIDINE NUCLEOSIDE DERIVATIVES IN CAPSULES | 2006 |
|
RU2428972C2 |
| CRYSTALLINE FORMS OF THIAZOLIDINEDIONE COMPOUNDS AND SYNTHESIS METHOD THEREOF | 2008 |
|
RU2414470C2 |
| CRYSTALLINE SUBSTANCE | 2018 |
|
RU2834293C2 |
| SALT AND CRYSTALLINE FORM OF COMPOUND HAVING S1P5 RECEPTOR AGONIST ACTIVITY | 2020 |
|
RU2833357C2 |
| PYRIMIDINE NUCLEOSIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND METHOD OF THEIR SYNTHESIS | 1992 |
|
RU2085557C1 |
| CRYSTALLINE INDOLESULFONAMIDE COMPOUND AND METHOD OF ITS OBTAINING | 2004 |
|
RU2336269C2 |
| CRYSTAL FORM OF PARP-1 INHIBITOR AND ITS PRODUCTION METHOD | 2018 |
|
RU2792620C2 |
| BILASTIN CRYSTALLINE FORMS AND THEIR PRODUCTION METHODS | 2016 |
|
RU2772222C2 |
| CRYSTALLINE FORM OF 3-METHYL-7-[4-(4-BENZHYDRYLPIPERAZINYL-1)BUTYL] XANTHINE SUCCINATE AND PHARMACEUTICAL COMPOSITION AND MEDICINAL AGENT CONTAINING THEREOF | 2022 |
|
RU2834474C2 |
| CRYSTALLINE FORMS OF GRAPIPRANT | 2015 |
|
RU2638931C1 |
